Listen Now

Topics Covered

  • Review of CLL
  • Significant Role of Testing in Informing Your Treatment Choices
  • First Line Treatment Options
  • Treatment of Relapsed/Refractory CLL
  • Importance of Re-Testing in Determining Treatment for 2nd and 3rd Line Treatments
  • Current Perspectives on New & Emerging Treatments for CLL
  • Key Questions to Ask & Re-Ask Your Health Care Team
  • Practical & Psychosocial Support to Cope with CLL
  • Questions for Our Panel of Experts

Our Panel of Experts

Alexey V. Danilov, MD, PhD

Associate Professor of Medicine, Knight Cancer Institute, Oregon Health & Science University (OHSU)

Lindsey E. Roeker, MD

Hematology/Medical Oncology Fellow, Department of Medicine, Memorial Sloan Kettering Cancer Center

Patricia Koffman

Co-Founder and Executive Director, CLL Society Inc.

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare


You can download the brochure for this workshop(pdf)(103 KB)

Workshop Date

This workshop was originally recorded on June 20, 2019.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.